/MSB

MSB

Updated 8 Oct 06:32 am

$1.935

MESOBLAST LIMITED

1D-3.01%
1M-15.50%
1Y-34.41%
Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Track your position in MSB

Sign in to TradeLedgr to record trades in MSB (MESOBLAST LIMITED) with broker-true precision and ATO-compliant reporting.

Recent Announcements

01 Oct 2026 8:49 AM
945KB
Ceasing to be a substantial holder
Ceasing to be a substantial holder
30 Sep 2026 8:15 AM
2458KB
Becoming a substantial holder
Becoming a substantial holder
23 Sep 2026 11:52 PM
575KB
FDA Approves New Potency Assay for Commercial Ryoncil
Progress Report
23 Sep 2026 8:41 AM
1016KB
Ceasing to be a substantial holder
Ceasing to be a substantial holder
26 Aug 2026 10:39 PM
386KB
MSB Annual Financial Results and Operational Update
Web Cast

Fundamentals

P/E Ratio

—

Div Yield

0.00%

EPS

$-0.0638

Avg Vol

—

52W High

$3.310

52W Low

$1.880

Company Profile

A biotechnology company in the area of adult stem cell technology.

Financial History

2026A

$-57.5M profit

$120.3M rev

2025A

$-102.1M profit

$17.2M rev

2024A

$-88.0M profit

$5.9M rev